» Articles » PMID: 15013013

Synthesis of Angiogenesis-targeted Peptide and Hydrophobized Polyethylene Glycol Conjugate

Overview
Specialty Biochemistry
Date 2004 Mar 12
PMID 15013013
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

For the purpose of cancer antineovascular therapy, a novel angiogenesis-targeted peptide, Ala-Pro-Arg-Pro-Gly, (APRPG) was attached to hydrophobized polyethylene glycol (distearoylphosphatidylethanolamine [DSPE]-PEG). DSPE-PEG and the 5-mer peptide were condensed with DCC-HOBt method. Liposome modified with this DSPE-PEG-APRPG conjugate highly accumulated in tumor of tumor-bearing mice.

Citing Articles

Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.

Xu J, Cao W, Wang P, Liu H Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890175 PMC: 9318328. DOI: 10.3390/ph15070876.


Effect of Nanoparticle Surface on the HPLC Elution Profile of Liposomal Nanoparticles.

Itoh N, Yamamoto E, Santa T, Funatsu T, Kato M Pharm Res. 2016; 33(6):1440-6.

PMID: 26928667 DOI: 10.1007/s11095-016-1886-4.


Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.

Asai T, Miyazawa S, Maeda N, Hatanaka K, Katanasaka Y, Shimizu K Cancer Sci. 2008; 99(5):1029-33.

PMID: 18294280 PMC: 11159210. DOI: 10.1111/j.1349-7006.2008.00758.x.